Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
about
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantationRituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma.Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas.Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients.Unresolved issues in diffuse large B-cell lymphomas.The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings.Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients.Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse.High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma.High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma.Cutaneous extra nodal lymphoma relapse: A case report and review of literature
P2860
Q28254421-449D8772-1755-4B4F-AC08-DEC5A5014A21Q33416550-B0C8E18B-0926-4A06-8BBC-0FA7EA50F9AEQ34570769-138A1F8D-9ECB-4034-AEEF-A3D4D46C3688Q36283067-C59EEBE2-14B5-4F39-A2FB-6C14D85A3513Q36379521-997C836E-606D-4061-B085-FAB3E27D522FQ37705417-0EFFE909-F7B3-4B7A-9D06-34F7218D02CFQ37824456-113C2724-A536-4882-87AE-2B17B28AC199Q38210641-EFD99A68-57B5-49CC-8D5A-9C68EEDB4A11Q40135669-53663DAD-17A2-483A-A835-B49AE40B533DQ44459148-BEE1C9F4-477B-43B3-B5A5-3956A1C90709Q44665402-A514BB6D-AB54-4E3A-AD2D-455A32108417Q46619094-26D70588-EBC1-432D-B8B5-175DF23E9889Q53114614-A75C6A7B-A502-4F9A-8FF7-5BF22363C67EQ58737343-A594EDD3-E2CC-4F35-BE4F-34DA85E73F95
P2860
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@en
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@nl
type
label
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@en
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@nl
prefLabel
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@en
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@nl
P2093
P2860
P1476
Intensification of salvage tre ...... essive non-Hodgkin's lymphoma.
@en
P2093
Benedetti F
Cortelazzo S
Di Nicola M
Ghielmini M
Pogliani E
Rambaldi A
P2860
P304
P356
10.1046/J.1365-2141.2001.02955.X
P407
P577
2001-08-01T00:00:00Z